Max Healthcare Institute Ltd. Share Price

Can Hospitals Be Scored Like Schools ?...

India may be moving toward a system where hospitals are judged not only by size and profits, but by the quality of patient outcomes. Imagine two hospitals performing the same surgery. One has fewer complications, fewer readmissions and better patient recovery. The other may have more beds and higher revenue but which one would you choose? That is the problem a proposed national hospital-quality framework could address. Instead of relying only on accreditation, patients could eventually get comparable data on: • Clinical outcomes & survival rates • Readmissions and complications • Hospital-acquired infections • Medication errors & patient safety • Patient experience and recovery The difficult part is fair comparison. A hospital treating older or critically ill patients may naturally show worse outcomes than one treating healthier patients. So any meaningful rating needs risk-adjusted data, adequate sample sizes and transparent methodology. If India starts measuring hospital quality more systematically, hospitals with strong clinical outcomes, established brands and expanding capacity could gain greater trust and patient preference. Max Healthcare Institute (MAXHEALTH)

Supreme Court Scrutiny on Medicine Mark-ups

Hospital stocks remain in the spotlight after the Supreme Court raised sharp concerns over steep mark-ups on medicines sold to patients at private hospitals. A bench flagged a cancer drug supplied to retailers at around ₹2,700 but carrying an MRP of ₹27,000 — nearly a tenfold difference — and questioned why the existing 16% trade margin cap on scheduled drugs has not been extended to non-scheduled medicines that dominate the market. The court also directed the Centre to examine practices compelling patients to buy from in-house or designated hospital pharmacies. The matter is listed for further hearing on October 12. The remarks triggered a sharp sell-off, with the BSE Hospitals Index falling about 5% and chains such as

Nifty Outlook for 01-Oct-2026 Looks Bearish

Nifty 50 closed Wednesday's session down 0.42% at 22,620.45, extending its slide below the critical technical handle of 23,000 for the third day in a row. The market remains firmly in the grip of the bears, with September locking in a sharp 6% decline, fueled by aggressive and sustained foreign institutional selling. The Daily MACD Histogram is below zero and the Hourly MACD Histogram is above zero and losing strength indicating bearish trend. The Daily RSI is below 30 and the Hourly RSI is below 40 indicating bearish trend. Thus, the overall trend of Nifty looks bearish, and the sellers are in control over the markets. Sell on rise would be the best strategy to deploy for today’s market considering the overall trend of Nifty. We may expect a change in trend only if the price sustains above the resistance level. Can Initiate buying only if prices continue to sustain above the resistance level. I have provided Nifty Spot resistance and support levels which would help you learn in taking informed trading decisions using these levels and understand how support and resistance levels work in financial markets. Nifty Spot Resistance 1 - 22735 Resistance 2 - 22770 Support 1 - 22520 Support 2 - 22490 Happy Learning, Happy Trading and have a wonderful day. Top Gainers : KOTAKBANK, INDIGO, ICICIBANK. Top Losers : APOLLOHOSP, MAXHEALTH, BSE.

Nifty Outlook for 22-Sep-2026 Looks Bearish

The NIFTY 50 setup for tomorrow, 28 September 2026, leans towards a cautiously constructive bias after closing at 23,140.50 (+0.34%) on Friday. While the index recovered slightly via value buying in late Friday trade, it logged its seventh consecutive weekly red close signalling dominant structural weakness on higher timeframes. The Daily MACD and Hourly MACD below zero indicates bearish trend. The Daily RSI (14) and Hourly RSI (14) below 40 also indicates a bearish trend. Thus, the overall trend of Nifty looks bearish, and the sellers are in control over the markets. Sell on rise would be the best strategy to deploy for today’s market considering the overall trend of Nifty. We may expect a change in trend only if the price sustains above the resistance level. Can Initiate buying only if prices continue to sustain above the resistance level. I have provided Nifty Spot resistance and support levels which would help you learn in taking informed trading decisions using these levels and understand how support and resistance levels work in financial markets. Nifty Spot Resistance 1 - 23245 Resistance 2 - 23275 Support 1 - 23085 Support 2 - 23070 Happy Learning, Happy Trading and have a wonderful day. Top Gainers : AXISBANK, ASIANPAINT, M&M. Top Losers : MAXHEALTH, TMPV, INFY.

Nifty Outlook for 10-Sep-2026 Looks Bearish

The overall trend of Nifty looks bearish, and the sellers are in control over the markets. Sell on rise would be the best strategy to deploy for today’s market considering the overall trend of Nifty. We may expect a change in trend only if the price sustains above the resistance level. Can Initiate buying only if prices continue to sustain above the resistance level. I have provided Nifty Spot resistance and support levels which would help you learn in taking informed trading decisions using these levels and understand how support and resistance levels work in financial markets. Nifty Spot Resistance 1 - 23550 Resistance 2 - 23590 Support 1 - 23350 Support 2 - 23330 Happy Learning, Happy Trading and have a wonderful day. Top Gainers : ADANIENT, ADANIPORTS, MAXHEALTH. Top Losers : INFY, HDFCLIFE, HCLTECH.

Max Healthcare - A decline with almost no volume behind it